FDA approves Aurobindo's new anti-infective

The Food and Drug Administration recently approved Aurobindo Pharma's anti-infective linezolid injection.

Linezolid — a generic form of Pharmacia & Upjohn's brand name Zyvox injection — is intended to treat infections caused by susceptible Gram-positive bacteria.

The newly approved drug has an estimated market value of $87 million for the 12 months ending in June 2016.

India-based Aurobindo Pharma expects to launch the product by the end of the second quarter. The linezolid injection marks the drugmaker's 275th FDA approval.

More articles on the drug market:

AbbVie sues Amgen for patent infringement on Humira: 5 things to know
Bristol-Myers stock dips 18% following failed trial
Drug company drives $48k brain-eating amoeba treatment to SC hospital

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars